Brief Research Report
Accepted on 11 Feb 2025
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network
in Inflammation Pharmacology
Brief Research Report
Accepted on 11 Feb 2025
in Inflammation Pharmacology
Original Research
Accepted on 11 Feb 2025
in Drugs Outcomes Research and Policies
Original Research
Accepted on 11 Feb 2025
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 11 Feb 2025
in Ethnopharmacology
Original Research
Accepted on 11 Feb 2025
in Inflammation Pharmacology
Clinical Trial
Accepted on 11 Feb 2025
in Ethnopharmacology
Review
Accepted on 11 Feb 2025
in Experimental Pharmacology and Drug Discovery
Review
Accepted on 11 Feb 2025
in Drug Metabolism and Transport
Mini Review
Accepted on 11 Feb 2025
in Pharmacogenetics and Pharmacogenomics
Review
Accepted on 11 Feb 2025
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 11 Feb 2025
in Experimental Pharmacology and Drug Discovery
Brief Research Report
Accepted on 11 Feb 2025
in Translational Pharmacology
Review
Published on 11 Feb 2025
in Experimental Pharmacology and Drug Discovery
Methods
Published on 11 Feb 2025
in Experimental Pharmacology and Drug Discovery
Review
Published on 11 Feb 2025
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 11 Feb 2025
in Pharmacoepidemiology